Projects we fund
Find out more about the research projects you’re helping us to fund, to create a better future for children with neuroblastoma.
![](/media/filer_public_thumbnails/filer_public/ad/ac/adac320d-0768-466f-94a8-94aec4b6f904/img_4839.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)
Senior Neuroblastoma Clinical Trials Coordinator
Solving Kid's Cancer UK has funded a specialised Senior Clinical Trials Coordinator post at the Cancer Research Clinical Trials Unit in Birmingham dedicated to working on trials for neuroblastoma.
![](/media/filer_public_thumbnails/filer_public/d6/47/d647f468-d2d5-4e24-9e2d-abea56322dba/pexels-anna-shvets-3844581.jpg__500x500_q85_crop_progressive_subject_location-1829%2C1600_subsampling-2_upscale.jpg)
Phase III TITAN trial
![](/media/filer_public_thumbnails/filer_public/9d/d6/9dd6d186-567f-4162-8b39-8a2824230aa3/pexels-karolina-grabowska-4226922c.jpg__500x500_q85_crop_progressive_subject_location-1941%2C1771_subsampling-2_upscale.jpg)
Solving Indolent Neuroblastoma
![](/media/filer_public_thumbnails/filer_public/3f/ec/3fec5c9d-274d-43be-b485-98f1a90f12d5/microscope_stock_image.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)
Europe-wide frontline high-risk neuroblastoma trial
![](/media/filer_public_thumbnails/filer_public/18/cd/18cdbff1-e943-40a9-a921-8061f94c4f90/brand_video_still-_research_nurses.png__500x500_crop_progressive_subsampling-2_upscale.png)
Phase I MiNivAn trial
![](/media/filer_public_thumbnails/filer_public/60/3e/603edf50-9edd-4e76-8276-1a7a93e456e2/pexels-anna-shvets-4483340.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)
Phase I trial of ALK inhibitor Lorlatinib
![](/media/filer_public_thumbnails/filer_public/4e/22/4e22396e-081b-4d19-b631-7cf8962193ab/pexels-thisisengineering-3913029.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)
CAR-T cells for treatment of neuroblastoma
![](/media/filer_public_thumbnails/filer_public/0c/7c/0c7cb1ae-d285-4fa1-a6a1-dc2d6be94335/pippette_stock_image.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)
Identifying markers of poor survival in high-risk neuroblastoma
![](/media/filer_public_thumbnails/filer_public/12/ee/12eecd34-3139-441b-ba84-72440360ec2e/research_-_treatment_stock_photo_2.jpg__500x500_q85_crop_progressive_subject_location-2674%2C1230_subsampling-2_upscale.jpg)
Evaluating biomarkers of neuroblastoma in the BEACON trial
![](/media/filer_public_thumbnails/filer_public/d9/6a/d96a3e4e-95ea-4346-808b-c0e44dd1da10/juliet_gray.jpg__500x500_q85_crop_progressive_subject_location-1241%2C1216_subsampling-2_upscale.jpg)
Introducing immunotherapy into the BEACON trial for high-risk neuroblastoma
![](/media/filer_public_thumbnails/filer_public/d6/f8/d6f8a4ff-5536-41a2-bca4-ab2fb93298cd/dr_robbie_majzner.jpg__500x500_q85_crop_progressive_subsampling-2_upscale.jpg)